On January 25, Exicure Inc. (XCUR) stock soared in the after-hours to gain a huge 28.24%. The stock seems to be gaining on external factors as there is no official announcement.
In the regular session, the stock fluctuated between $0.1670 and $0.1501 at 21.25 million shares. XCUR stock closed the session at $0.1629, adding 3.56%. Soon in the after-hours, the stock saw an upsurge as it rose to $0.2089 on Tuesday.
The Spherical Nucleic Acid-based therapeutics developer, Exicure Inc. has a market capitalization of $17.11 million. Currently, the company has 108.78 million shares outstanding in the market.
XCUR stock Movement
After being in a downtrend for the past few days, XCUR stock seems to be in recovery mode right now. The stock touched a low of $0.1420 yesterday, just a little short of its 52-week low of $0.1415. Consequent to this, the stock saw a heavy volume during both the following sessions. In regular trading, the stock traded at 572% of the average volume while it was 11.69 million shares in the after-hours. The recent near low might have something to do with the stock’s comeback along with other external factors. Since, there is no official announcement, SEC filing, or upcoming event in the company’s timeline, external factors seem to be at play here.
A further study of the stock movement shows a year-to-date loss of 19.40% for XCUR. Moreover, the stock lost a humungous 92.66% last year.
Recent SEC Filing
On January 14, the company filed a report with the Securities Exchange Commission. As per the report, XCUR’s board gave a promotion to the company’s Chief Accounting Officer, Elais D. Papadimas. Mr. Papadimas was promoted to the role of Chief Financial Officer, effective January 17, 2022. Moreover, he was also appointed as the company’s corporate secretary.
In addition, Mr. Papadimas’ promotion resulted in the increase of his annual base salary from $300,000 to $405,000. Also, his target bonus percentage was increased by a further 10% of his annual base salary.
Furthermore, the increase in the base salary and target bonus percentage was a result of an amendment to his Amended and Restated Employment Agreement. The amendment also makes Mr. Papadimas eligible for a special bonus.
XCUR’s Financial Overview
In the third quarter of 2021, the company suffered from a net loss of $23.5 million, against $8.8 million in the year-ago quarter.
Additionally, XCUR ended the quarter with cash, cash equivalents, short-term investments, and restricted cash of $62.0 million.
